AQUALINK
Live / Applied — Response to non-final action entered (as of 10 Sept 2026)
What this means for you
Not registered yet, but its 06 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99686197
- Mark type
- Stylized text
- Filed
- 06 Mar 2026
- Attorney of record
- Christopher D Olszyk, Jr.
Goods and services
- Class 001 — Chemicals: Chemical substances for use in the connection of small and large molecules to antibodies for use in scientific and medical research; Chemical, biochemical and biological reagents for scientific or medical research use; Diagnostic preparations for scientific and medical research use in the field of antibody conjugates for scientific and medical research; Hydrophilic chemical connectors for scientific purposes, other than for medical or veterinary purposes; Biologics, namely, antibodies used to covalently attach a small or large molecule to an antibody, for scientific and medical research; Biologics, namely, antibodies incorporating hydrophilic chemical connectors for use in covalently attaching a small or large molecule to an antibody, for scientific and medical research.
- Class 005 — Pharmaceuticals: Diagnostic preparations, namely, antibodies incorporating hydrophilic chemical connectors for use in covalently attaching a small or large molecule to an antibody, for medical diagnosis and treatment purposes; Delivery agents for antibodies, namely, drug delivery agents in the form of hydrophilic chemical connectors that facilitate the delivery and action of medical preparations; Diagnostic preparations, namely, hydrophilic chemical connectors for use in covalently attaching a small or large molecule to an antibody, for use in the fields of medical diagnosis and treatment; Chemical, biological and biochemical preparations for medical and pharmaceutical use, namely, hydrophilic chemical connectors for medical diagnosis and treatment in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Pharmaceutical preparations and diagnostic preparations medical articles, namely, hydrophilic chemical connectors for medical diagnosis and disease treatment in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders.
- Class 042 — Scientific and technological services: Research and development of hydrophilic chemical connectors; Scientific research for medical purposes in the field of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Research and development services in the field of antibodies; Antibody engineering; Custom design and engineering of antibodies; Research and development of pharmaceuticals for the treatment of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Research, development and establishment of testing specifications and procedures in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders research, diagnosis and treatment; Providing scientific research information in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders research, diagnosis and treatment; Scientific and technological services and research relating thereto, namely, research, analysis and testing in the fields of antibodies, antibody conjugates, and hydrophilic chemical connectors
Owner
- Aarvik Therapeutics, Inc., Hayward, CA, US
Prosecution history
- 10 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Jun 2026 — NON-FINAL ACTION E-MAILED
- 16 Jun 2026 — NON-FINAL ACTION WRITTEN
- 15 Jun 2026 — ASSIGNED TO EXAMINER
- 15 Jun 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 06 Mar 2026 — NEW APPLICATION ENTERED